Skip to main content
Year archive

Ascelia Pharma — 2019 filings

All 39 regulatory filings released by Ascelia Pharma (ACE) in 2019, sourced directly from the official regulator.

39 Filings
2019 Period
2019 filings (39)
Filing Released Lang
Nomination Committee appointed for AGM 2020 in Ascelia Pharma AB
Board/Management Information
2019-12-18 English
Valberedning utsedd inför årsstämma 2020 i Ascelia Pharma AB
AGM Information
2019-12-18 Swedish
Ascelia Pharma utser Julie Waras Brogren till Chief Commercial Officer
Board/Management Information
2019-12-09 Swedish
Ascelia Pharma appoints Julie Waras Brogren as Chief Commercial Officer
Board/Management Information
2019-12-09 English
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 14 November 2019
AGM Information
2019-11-14 English
Kommuniké från årsstämma den 14 november 2019 i Ascelia Pharma AB
AGM Information
2019-11-14 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-11-08 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-11-08 English
Förändring i Ascelia Pharmas ledningsgrupp
Board/Management Information
2019-10-25 Swedish
Change in Ascelia Pharma’s management team
Board/Management Information
2019-10-25 English
Annual Report 2019
Annual Report FY 2019
2019-10-14 Swedish
Annual Report 2019
Annual Report FY 2019
2019-10-14 English
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2019-08-22 Swedish
Annual Report 2019
Annual Report FY 2019
2019-08-22 English
Ascelia Pharma strengthens its Mangoral franchise by filing of a patent application for next generation Mangoral product
Regulatory Filings
2019-06-10 English
Ascelia Pharma stärker ställningen för Mangoral med en patentansökan för nästa generations Mangoral-produkt
Investor Presentation
2019-06-10 Swedish
Earnings Release 2019
Earnings Release Q1 2019
2019-05-15 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-15 English
Ascelia Pharma håller telekonferens för presentation av kvartalsrapport
Report Publication Announcement
2019-05-13 Swedish
Ascelia Pharma to host teleconference for presentation of interim financial report
Report Publication Announcement
2019-05-13 English
Nomination Committee appointed for AGM 2019 in Ascelia Pharma AB
Board/Management Information
2019-05-10 English
Valberedning utsedd inför årsstämma 2019 i Ascelia Pharma AB
AGM Information
2019-05-10 Swedish
Ascelia Pharma fick positiv feedback från EMA gällande fas 3-programmet för Mangoral®
Legal Proceedings Report
2019-05-07 Swedish
Ascelia Pharma received supportive feedback from EMA on the phase 3 program for Mangoral®
Regulatory Filings
2019-05-07 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-05-02 English
Ändring av antalet aktier och röster i Ascelia Pharma AB (publ)
Share Issue/Capital Change
2019-04-30 Swedish
Change in number of shares and votes in Ascelia Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-04-30 English
Exercise of over-allotment option, stabilisation notice and end of the stabilisation period
Share Issue/Capital Change
2019-04-12 English
Utnyttjande av övertilldelningsoption, meddelande om stabiliseringsåtgärder och avslutande av stabiliseringsperiod
Capital/Financing Update
2019-04-12 Swedish
Meddelande om stabiliseringsåtgärder
Share Issue/Capital Change
2019-04-11 Swedish
Stabilisation notice
Regulatory Filings
2019-04-11 English
Encouraging results from the Phase I combination study with Oncoral and oral capecitabine published in the journal Cancer Chemotherapy and Pharmacology
Earnings Release FY 2019
2019-04-08 English
Lovande fas-1 resultat när Oncoral kombineras med det orala läkemedlet capecitabin. Resultaten publiceras i tidskriften Cancer Chemotherapy and Pharmacology
Regulatory Filings
2019-04-08 Swedish
Stabilisation notice
Report Publication Announcement
2019-04-01 English
Meddelande om stabiliseringsåtgärder
Share Issue/Capital Change
2019-04-01 Swedish
Change in number of shares and votes in Ascelia Pharma AB (publ)
Share Issue/Capital Change
2019-03-29 English
Ändring av antalet aktier och röster i Ascelia Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2019-03-29 Swedish
Stabilisation notice
Regulatory Filings
2019-03-21 English
Meddelande om stabiliseringsåtgärder
Share Issue/Capital Change
2019-03-21 Swedish